Guangdong Hybribio Biotech Co.,Ltd. (300639.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.38B
Enterprise Value2.75B
P/E Ratio-32.31
PEG Ratio-0.22
Price/Sales Ratio5.35
Price/Book Ratio0.9
Enterprise/Revenue4.32
Enterprise/EBITDA-445.88

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.16
Operating Margin-0.24
AD

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.03

Income Statement

Revenue665.17M
Revenue/Share1.05
Gross Profit215.41M
EBITDA11.12M
Net Income-130.94M
Diluted EPS-0.21

Balance Sheet

Total Cash950.87M
Total Cash/Share1.52
Total Debt87.31M
Total Debt/Equity0.02
Current Ratio5.3
Book Value Per Share5.93

Price History

52-Week Change-2.32
52-Week High10.07
52-Week Low5.1
Moving Average 50 Days6.05
Moving Average 200 Days6.12

Statistics

Average Volume25.56M
Shares Outstanding646.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.02
Last Split Factor3:2
Last Split DateMay 22, 2023
AD